SHREE GANESH REMEDIES Financial Statement Analysis
|
||
|
The Revenues of SHREE GANESH REMEDIES have increased by 37.80% YoY .
The Earnings Per Share (EPS) of SHREE GANESH REMEDIES has increased by 80.31 % YoY. |
||
| REVENUES |
| OPERATING MARGIN |
| PROFIT AFTER TAX |
| EPS |
| ROCE |
SHREE GANESH REMEDIES Last 5 Annual Financial Results
[BOM: 540737]
| Standalone | Mar2024 | Mar2023 | Mar2022 | Mar2021 | Mar2020 |
|---|---|---|---|---|---|
| Revenues | ₹126 Cr | ₹91 Cr | ₹71 Cr | ₹49 Cr | ₹58 Cr |
| Expenses | ₹84 Cr | ₹68 Cr | ₹53 Cr | ₹35 Cr | ₹47 Cr |
| Operating Profit (Excl OI) | ₹42 Cr | ₹23 Cr | ₹18 Cr | ₹14 Cr | ₹11 Cr |
| Other Income | ₹3.07 Cr | ₹0.72 Cr | ₹3.57 Cr | ₹2.09 Cr | ₹4.18 Cr |
| Interest | ₹0.60 Cr | ₹0.18 Cr | ₹0.15 Cr | ₹0.07 Cr | ₹0.14 Cr |
| Depreciation | ₹6.11 Cr | ₹3.74 Cr | ₹3.34 Cr | ₹2.73 Cr | ₹2.24 Cr |
| Profit Before Tax | ₹38 Cr | ₹20 Cr | ₹18 Cr | ₹13 Cr | ₹13 Cr |
| Profit After Tax | ₹28 Cr | ₹15 Cr | ₹13 Cr | ₹9.75 Cr | ₹9.63 Cr |
| Earnings Per Share (Rs) | ₹21.89 | ₹12.14 | ₹11.16 | ₹9.75 | ₹10.73 |
| PAT Margin (%) | 21.74 | 16.44 | 18.80 | 19.87 | 16.47 |
| ROE(%) | 26.87 | 20.41 | 24.02 | 21.18 | 25.35 |
| ROCE(%) | 27.83 | 22.46 | 32.47 | 27.51 | 32.63 |
| Total Debt/Equity(x) | 0.30 | 0.38 | 0.00 | 0.00 | 0.05 |
Key Financials |
||
| Market Cap | : | ₹ 879.0 Cr |
| Revenue (TTM) | : | ₹ 122.4 Cr |
| Net Profit(TTM) | : | ₹ 28.5 Cr |
| EPS (TTM) | : | ₹ 22.2 |
| P/E (TTM) | : | 30.9 |
| Industry Peers & Returns | 1W | 1M | 1Y |
| SHREE GANESH REMEDIES | -5.1% | 2.4% | 1% |
| SUN PHARMACEUTICAL INDUSTRIES | -0.1% | 1.7% | 45.7% |
| CIPLA | 1.7% | 0.5% | 23.7% |
| DR REDDYS LABORATORIES | 5.7% | 12.4% | 18.5% |
| ZYDUS LIFESCIENCES | -1.4% | 3.1% | 44.8% |
| DIVIS LABORATORIES | -0.1% | -2.2% | 56.9% |
| MANKIND PHARMA | 4.2% | 9.8% | 49.8% |
| TORRENT PHARMACEUTICALS | 2.2% | 10.6% | 61.7% |
| LUPIN | 4.1% | 5.1% | 71.7% |
SHREE GANESH REMEDIES Revenues
[BOM: 540737]
| Y-o-Y | 37.80 % |
| 5 Yr CAGR | 21.16 % |
| Years | Revenues | % Change | |
|---|---|---|---|
| Mar2024 | ₹126 Cr | 37.80 | |
| Mar2023 | ₹91 Cr | 28.15 | |
| Mar2022 | ₹71 Cr | 45.26 | |
| Mar2021 | ₹49 Cr | -16.00 | |
| Mar2020 | ₹58 Cr | - | |
SHREE GANESH REMEDIES Operating Profit
[BOM: 540737]
| Y-o-Y | 78.35 % |
| 5 Yr CAGR | 39.80 % |
| Years | Operating Profit | % Change | |
|---|---|---|---|
| Mar2024 | ₹42 Cr | 78.35 | |
| Mar2023 | ₹23 Cr | 30.82 | |
| Mar2022 | ₹18 Cr | 31.30 | |
| Mar2021 | ₹14 Cr | 24.67 | |
| Mar2020 | ₹11 Cr | - | |
| Operating Margins | |
|---|---|
| Y-o-Y | 29.42 % |
| 5 Yr CAGR | 15.38 % |
| Years | Operating Margin% | % Change | |
|---|---|---|---|
| Mar2024 | 33.21% | 29.42 | |
| Mar2023 | 25.66% | 2.07 | |
| Mar2022 | 25.14% | -9.60 | |
| Mar2021 | 27.81% | 48.40 | |
| Mar2020 | 18.74% | - | |
SHREE GANESH REMEDIES Profit After Tax
[BOM: 540737]
| Y-o-Y | 85.17 % |
| 5 Yr CAGR | 30.74 % |
| Years | Profit After Tax | % Change | |
|---|---|---|---|
| Mar2024 | ₹28 Cr | 85.17 | |
| Mar2023 | ₹15 Cr | 13.33 | |
| Mar2022 | ₹13 Cr | 37.37 | |
| Mar2021 | ₹9.75 Cr | 1.34 | |
| Mar2020 | ₹9.63 Cr | - | |
| PAT Margins | |
|---|---|
| Y-o-Y | 32.24 % |
| 5 Yr CAGR | 7.19 % |
| Years | PAT Margin(%) | % Change | |
|---|---|---|---|
| Mar2024 | 21.74 % | 32.24 | |
| Mar2023 | 16.44 % | -12.55 | |
| Mar2022 | 18.8 % | -5.39 | |
| Mar2021 | 19.87 % | 20.64 | |
| Mar2020 | 16.47 % | - | |
SHREE GANESH REMEDIES Earnings Per Share (EPS)
[BOM: 540737]
| Y-o-Y | 80.31 % |
| 5 Yr CAGR | 19.51 % |
| Years | EPS | % Change | |
|---|---|---|---|
| Mar2024 | ₹22 | 80.31 | |
| Mar2023 | ₹12 | 8.78 | |
| Mar2022 | ₹11 | 14.46 | |
| Mar2021 | ₹9.75 | -9.13 | |
| Mar2020 | ₹11 | - | |
SHREE GANESH REMEDIES Return on Capital Employed (ROCE)
[BOM: 540737]
| Y-o-Y | 23.91 % |
| 5 Yr CAGR | -3.90 % |
| Years | ROCE | % Change | |
|---|---|---|---|
| Mar2024 | 27.83% | 23.91 | |
| Mar2023 | 22.46% | -30.83 | |
| Mar2022 | 32.47% | 18.03 | |
| Mar2021 | 27.51% | -15.69 | |
| Mar2020 | 32.63% | - | |
SHREE GANESH REMEDIES Share Price vs Sensex
| Current Share Price | : | ₹686.7 |
| Current MarketCap | : | ₹ 879.0 Cr |
| Updated EOD on | : | Dec 20,2024 |
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| SHREE GANESH REMEDIES | -5.1% |
2.4% |
1% |
| SENSEX | -5% |
0.6% |
9.2% |
SHREE GANESH REMEDIES related INDICES
No BSE index found!
No NSE index found
You may also like the below Video Courses
FAQ about SHREE GANESH REMEDIES Financials
How the annual revenues of SHREE GANESH REMEDIES have changed ?
The Revenues of SHREE GANESH REMEDIES have increased by 37.80% YoY .
How the Earnings per Share (EPS) of SHREE GANESH REMEDIES have changed?
The Earnings Per Share (EPS) of SHREE GANESH REMEDIES has increased by 80.31 % YoY .
Check out Intrinsic Value of Peers of SHREE GANESH REMEDIES
Compare Stock Analytics of Peers of SHREE GANESH REMEDIES
SUN PHARMACEUTICAL INDUSTRIES LTD vs CIPLA LTD vs DR REDDYS LABORATORIES LTD
ZYDUS LIFESCIENCES LTD vs DIVIS LABORATORIES LTD vs
SUN PHARMACEUTICAL INDUSTRIES LTD vs CIPLA LTD vs DR REDDYS LABORATORIES LTD
ZYDUS LIFESCIENCES LTD vs DIVIS LABORATORIES LTD vs
